| Income Statement | 2026-06-30 | |||
|---|---|---|---|---|
| Revenue net | 7,998 | |||
| Cost of revenue | 10,312 | |||
| Amortization expense | 4,185 | |||
| Research and development expensesnet | 367,292 | |||
| Sales and marketing expenses | 29,328 | |||
| General and administrative expenses | 151,907 | |||
| Total costs and expenses | 563,024 | |||
| Loss from operations | -555,026 | |||
| Interest incomenet | 4,719 | |||
| Loss on change in fair value of warrant liabilities | 47,615 | |||
| Other (income)/expensenet | 1,971 | |||
| Loss before taxes | -595,951 | |||
| Tax expense | 569 | |||
| Net loss | -596,520 | |||
| Less net loss attributable to quantinuum (cayman) prior to the transactions | -110,087 | |||
| Less net loss attributable to the non-controlling interest | -421,015 | |||
| Net loss attributable to quantinuum inc | -65,418 | |||
| Basic EPS | -1.93 | |||
| Diluted EPS | -1.93 | |||
| Basic Average Shares | 33,914,995 | |||
| Diluted Average Shares | 33,914,995 | |||
Quantinuum Inc. (QNT)
Quantinuum Inc. (QNT)